COVID-19 Update

CEO letter to business partners, customers and end-users

Smart choices for everyday healthcare

Karo Pharma offers a portfolio of everyday healthcare products and services that help prevent illness and treat health problems.

With a wide range of trusted, documented and original brands, backed by services for partners, customers and consumers, we provide people with the options, knowledge and access they need to stay healthy. We call it smart choices for everyday healthcare.

We specialise in six product categories: intimate care; dermatology; footcare; pain, cough and cold; wellness; and Rx pharma care. Across these categories, we own a range of differentiated brands in both prescription drugs (Rx) and consumer products (OTC).

Through strategic acquisitions and organic growth we work to expand our geographical reach in Europe and strengthen our distinctive positions in the categories we operate in.

News from Karo Pharma

25 May, 2020

ANNUAL GENERAL MEETING 2020 IN KARO PHARMA AKTIEBOLAG

At today’s annual general meeting of Karo Pharma, the following decisions were passed. The annual general meeting resolved to adopt…

8 May, 2020

Karo Pharma acquires Pevaryl^® brand portfolio from Cilag GmbH International, an affiliate of Johnson & Johnson

Karo Pharma Aktiebolag (“Karo Pharma”) today announces the signing and closing of the acquisition of the remaining European rights to…

1 April, 2020

Karo Pharma enters the Swiss market with direct presence by acquiring Hygis SA

Karo Pharma AB (Karo) has today acquired Hygis SA (Hygis), a Swiss distributing company with exclusive distribution rights to Karo’s…

See all news

Recent reports

21 July, 2020

Second-quarter report 2020

Q2, April – June Net sales amounted to MSEK 688.9 (387.4). This corresponds to an increase of 78% for the…

29 April, 2020

Interim report Q1 2020

January – March Net sales amounted to MSEK 793.6 (420.8). This corresponds to an increase of 89% for the period.…

1 April, 2020

Karo Pharma publishes the 2019 annual report

Today, on 1 April 2020, Karo Pharma is publishing its annual report for 2019 on the company’s website, www.karopharma.com. FOR…

See all reports

About Karo Pharma

Karo Pharma offers a portfolio of everyday healthcare products and services that help prevent illness and treat health problems.

Mergers and acquisitions

We work to expand our geographical reach and build a distinctive position in each of the categories we operate in.

Investors

Karo Pharma delivers smart choices for everyday healthcare. A simple statement but one that defines our choices when it comes to the way we grow.

Wortie

Wortie offers effective, safe, and easy to use treatments against warts and verrucas. Wortie has a range of products with different treatment styles to fit with individual prefrances, so that it is easy to treat at home. Worties patanted cyrotheropy products is the heros of the rang, with the unique metaltip only the wart of...

Locobase

Locobase is a well-established skincare brand, recommended by health care professionals and pharmacy staff. Locobase is an international brand being sold in around 40 countries with a strong position mainly on the Nordic market. Locobase is clinically proven to be gentle to sensitive skin and highly suitable for eczema-prone skin. Locobase is available as Repair,...

Viruseptin

Viruseptin is a dual-acting cold spray that can be used for prevention and treatment of nasal and pharyngeal infections. Viruseptin effectively prevents viruses from spreading and can, if the cold has already broken out, shorten the disease period and reduce the risk of a recurring infection. Viruseptin is the first cold spray that has had...

View more products